Anatomic Endoscopic Prostate Enucleation and BICEP Classification
BICEP
Multicentric Prospective Evaluation of Bladder Injuries During Morcellation Using BICEP (Bladder Injury Classification During Endoscopic Procedures)
1 other identifier
observational
250
1 country
2
Brief Summary
The Bladder Injury Classification System for Endoscopic Procedure (BICEP) is designed to provide a systematic framework for categorizing bladder injuries that occur during endoscopic procedures. By standardizing the classification of these injuries, BICEP promotes a more consistent approach to diagnosis, management, and prevention across different urologic interventions. This study aims to validate and implement the BICEP system during morcellation. This study will: Validate BICEP by using real-life clinical scenarios to ensure its applicability and effectiveness. Assess the incidence and types of bladder injuries during morcellation, using the BICEP categorization to standardize injury reporting and enhance treatment protocols.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2025
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2024
CompletedFirst Posted
Study publicly available on registry
June 21, 2024
CompletedStudy Start
First participant enrolled
October 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 14, 2025
CompletedNovember 18, 2025
May 1, 2025
1 month
June 4, 2024
November 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants with Successful Validation of the Bladder Injury Classification System for Endoscopic Procedure Classification System for Bladder Injuries Occurring During Morcellation in AEEP Operations
Approximately 250 participants will be evaluated using a scoring system ranging from 0 to 4 to assess the severity of the injury. A score of 0 indicates no injury, while a score of 4 indicates extensive avulsion of part of the bladder. In this system, the severity of the injury increases as the score increases.
Up to 24 weeks
The impact of different energy sources and morcellation devices on bladder injury
The severity of the injury will be assessed using a scoring system ranging from 0 to 4. A score of 0 indicates no injury, while a score of 4 indicates the highest degree of avulsion of part of the bladder. In this system, the severity of the injury increases as the score increases.
Up to 24 weeks
Secondary Outcomes (4)
Postoperative Qmax Increase Following Morcellation in AEEP Operations
1 month post surgery
Postoperative Improvement in International Prostate Symptom Score (IPSS)
1 month post surgery
Duration of catheterization
Up to 10 weeks
Length of hospital stay
Up to 6 weeks
Interventions
The intervention in this study involves performing anatomic endoscopic enucleation of the prostate (AEEP) using different energy sources. Following the enucleation, the resected prostate tissue will be morcellated within the bladder using various morcellators to remove the enlarged prostate tissue minimally invasively. The process will also involve evaluating and categorizing any resulting bladder injuries using the BICEP classification system.
Eligibility Criteria
Participants will include adult patients undergoing AEEP surgery. The presence of bladder injuries during the operation will be assessed according to the BICEP classification, and any potential injuries will be recorded.
You may qualify if:
- Patients aged ≥40
- ASA (American Society of Anesthesiologists) score ≤4
- Patients undergoing Holmium Laser Enucleation of the Prostate (HoLEP) or Transurethral Resection of the Prostate (TURP) surgery.
You may not qualify if:
- Patients with neurological disorders that may affect bladder function, such as cerebrovascular stroke or Parkinson's disease.
- Patients with active urinary tract infection.
- Patients diagnosed with bladder cancer within the last 2 years.
- Patients with prostate cancer.
- Patients who have undergone previous prostate surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Necmettin Erbakan Universitylead
- Danube University Kremscollaborator
- University General Hospital of Heraklioncollaborator
- Paracelsus Medical Universitycollaborator
- University of Turin, Italycollaborator
- Menoufia Universitycollaborator
- Acibadem Ankara Hospitalcollaborator
- Universitätsmedizin Mannheimcollaborator
- Martini-Klinik am UKE GmbHcollaborator
- Asklepios Kliniken Hamburg GmbHcollaborator
- Istanbul Medipol University Hospitalcollaborator
- Saint Petersburg State University, Russiacollaborator
- HM Sanchinarro University Hospitalcollaborator
- Alexandria Universitycollaborator
- Spital Thurgau AGcollaborator
- Medical University of Grazcollaborator
- King's College Hospital NHS Trustcollaborator
- Sheikh Khalifa Medical Citycollaborator
Study Sites (2)
Necmettin Erbakan University
Konya, Konya, 42250, Turkey (Türkiye)
Istanbul Medipol University Hospital
Istanbul, Turkey (Türkiye)
Related Publications (3)
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.
PMID: 19638912RESULTBreda A, Gallioli A, Diana P, Fontana M, Territo A, Gaya JM, Rodriguez-Faba O, Huguet J, Piana A, Verri P, Baboudjian M, Aumatell J, Algaba F, Palou J. The DEpth of Endoscopic Perforation scale to assess intraoperative perforations during transurethral resection of bladder tumor: subgroup analysis of a randomized controlled trial. World J Urol. 2023 Oct;41(10):2583-2589. doi: 10.1007/s00345-022-04052-w. Epub 2022 Jun 4.
PMID: 35665840RESULTGilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR. Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol. 1998 Oct;12(5):457-9. doi: 10.1089/end.1998.12.457.
PMID: 9847070RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Selçuk Güven, Prof. Dr.
Necmettin Erbakan University
- STUDY CHAIR
Bülent Erkurt, Prof. Dr.
Istanbul Medipol University Hospital
- PRINCIPAL INVESTIGATOR
Selim Soytürk, RA
Necmettin Erbakan University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
June 4, 2024
First Posted
June 21, 2024
Study Start
October 8, 2025
Primary Completion
November 14, 2025
Study Completion
November 14, 2025
Last Updated
November 18, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share